Top Markets
#1 MowCat MowCat +49.48%
#2 Velvet Velvet +22.01%
#3 Block Street Block Street +17.94%
#4 Perle Perle +17.51%
#5 Quack AI Quack AI +16.48%
#6 Fake World Assets Fake World Assets +16.44%
#7 Derive Derive +14.43%
#8 Bermuda Shorts Bermuda Shorts +13.97%
#9 Epic Chain Epic Chain +13.90%
#10 DUSK Network DUSK Network +12.90%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Integrated BioPharma, Inc. Integrated BioPharma, Inc.

Integrated BioPharma, Inc.

INBP
Rank in Stocks #34626
Integrated BioPharma, Inc., together with its subsidiaries, engages in the... Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Share Price
$0.16795
Last synced: 2026-08-14
Market Cap
$5.22M
Change (1 day)
4.97%
Change (1 year)
-37.80%
Country
US
Trade Integrated BioPharma, Inc. (INBP)

Category

Healthcare
Earnings for Integrated BioPharma, Inc. (INBP)
Earnings in 2026 TTM: 0
According to Integrated BioPharma, Inc. latest financial reports the company's current earnings are 0. In 2026 the company made an earning of 0, equal to its 2026 earnings that were of 0. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Integrated BioPharma, Inc. from 2026 to 2026
Earnings at the end of each year
Year Earnings Change
Not enough data for the provided dates.
Earnings for similar companies or competitors
Company Earnings Earnings Difference Country
Royalty Pharma plc Royalty Pharma plc
Royalty Pharma plc
RPRX.US
$1.35B -
US
Swedish Orphan Biovitrum AB Swedish Orphan Biovitrum AB
Swedish Orphan Biovitrum AB
SOBI.ST
- -
SE
Ipsen S.A. Ipsen S.A.
Ipsen S.A.
IPN.PA
- -
FR
Recordati Industria Chimica e Farmaceutica S.p.A. Recordati Industria Chimica e Farmaceutica S.p.A.
Recordati Industria Chimica e Farmaceutica S.p.A.
REC.MI
- -
IT
Corcept Therapeutics Incorporated Corcept Therapeutics Incorporated
Corcept Therapeutics Incorporated
CORT.US
$26.37M -
US